Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02379910
What this trial is testing

Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AnaMar AB 36
Early research (Phase 1)Looking for participantsNCT07025018
What this trial is testing

Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations

Who this might be right for
Gliomas Harboring IDH1 and/or IDH2 Mutations
Hutchmed 52
Testing effectiveness (Phase 2)Study completedNCT03763318
What this trial is testing

Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD

Who this might be right for
Acute-graft-versus-host DiseaseaGVHDGVHD+1 more
Biocon Limited 30
Early research (Phase 1)Study completedNCT06308523
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants

Who this might be right for
Healthy Subjects
Alebund Pharmaceuticals 18
Early research (Phase 1)Study completedNCT04079062
What this trial is testing

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects

Who this might be right for
Healthy Volunteers
Ono Pharmaceutical Co., Ltd. 78
Testing effectiveness (Phase 2)Study completedNCT02913482
What this trial is testing

Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 62
Testing effectiveness (Phase 2)Looking for participantsNCT06625671
What this trial is testing

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Who this might be right for
Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus
DualityBio Inc. 148
Early research (Phase 1)Study completedNCT03634436
What this trial is testing

The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

Who this might be right for
Hypercholesteremia
Jiangsu HengRui Medicine Co., Ltd. 32
Early research (Phase 1)Study completedNCT03965533
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects

Who this might be right for
Healthy Volunteers
GlaxoSmithKline 36
Early research (Phase 1)Looking for participantsNCT06671093
What this trial is testing

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

Who this might be right for
Chronic Hep BChronic Hepatitis bChronic Hepatitis+1 more
Tune Therapeutics, Inc. 36
Early research (Phase 1)Study completedNCT00739999
What this trial is testing

8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Pediatric Heterozygous Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 39
Early research (Phase 1)Active Not RecruitingNCT05167071
What this trial is testing

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Who this might be right for
Solid TumorsNeuroendocrine TumorsCRC
Harbour BioMed (Guangzhou) Co. Ltd. 53
Large-scale testing (Phase 3)Ended earlyNCT06121375
What this trial is testing

Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy

Who this might be right for
Biliary Atresia
Intercept Pharmaceuticals 28
Early research (Phase 1)Study completedNCT01094860
What this trial is testing

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00705536
What this trial is testing

Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20

Who this might be right for
Diabetes Mellitus
Halozyme Therapeutics 26
Early research (Phase 1)Study completedNCT03244228
What this trial is testing

A Two Part Study to Assess Safety, PK, PD, and Food Effect of Oral HTL0016878

Who this might be right for
Healthy
Nxera Pharma UK Limited 120
Testing effectiveness (Phase 2)Study completedNCT02435212
What this trial is testing

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Who this might be right for
Transfusion-dependent Anemia
Novartis Pharmaceuticals 224
Early research (Phase 1)Study completedNCT01155453
What this trial is testing

Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Who this might be right for
Advanced and Selected Solid Tumors
Novartis Pharmaceuticals 113
Testing effectiveness (Phase 2)UnknownNCT05602129
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

Who this might be right for
Renal Replacement Therapy
Haisco Pharmaceutical Group Co., Ltd. 156
Early research (Phase 1)Study completedNCT05979207
What this trial is testing

Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

Who this might be right for
InfectionsVector Borne DiseasesSystemic Inflammatory Response Syndrome+9 more
Medicines for Malaria Venture 12
Next Page